Coverage dated October 28, 2026 to October 29, 2026

HHS gives compounding pharmacies free rein to make certain peptides

Headline from The Hill

Presented by Alliance for Aging Research {beacon} Health Care Health Care The Big Story HHS gives compounding pharmacies free rein to make certain peptides Without finalizing any new approvals or regulatory changes, the Department of Health and Human Services (HHS) on Wednesday gave compounding phar…

The Hill's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Reports & sources

5 articles, oldest first.

  1. Bloomberg

    US to Allow Compounding of Six Peptides in Temporary Plan (opens Bloomberg)

    Published

    Bloomberg's feed description

    The Department of Health and Human Services on Wednesday announced plans to temporarily allow compounding pharmacies to produce six peptides.

  2. The Hill

    HHS to allow sale of unapproved peptides under review (opens The Hill)

    Published

    The Hill's feed description

    The Department of Health and Human Services (HHS) will allow compounding pharmacies to manufacture and sell peptides that have not yet been added to the list of approved substances, advancing access to the those championed by the Make America Healthy Again (MAHA) agenda.

  3. The Hill

    HHS gives compounding pharmacies free rein to make certain peptides (opens The Hill)

    Published

    The Hill's feed description

    Presented by Alliance for Aging Research {beacon} Health Care Health Care The Big Story HHS gives compounding pharmacies free rein to make certain peptides Without finalizing any new approvals or regulatory changes, the Department of Health and Human Services (HHS) on Wednesday gave compounding phar…

  4. NPR

    Trump administration will allow pharmacies to make popular peptides (opens NPR)

    Published

    NPR's feed description

    The Department of Health and Human Services will let small compounding pharmacies make six peptides that haven't been approved by the Food and Drug Administration. It may not be enough to meet demand.

  5. STAT

    STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and more (opens STAT)

    Published

    STAT's feed description

    HHS released a policy that will temporarily allow compounding pharmacies to manufacture some peptide products

HHS gives compounding pharmacies free rein to make certain peptides | Since Then